Publication Name	World Journal of Gastroenterology
Manuscript ID	16652
Country	Japan

Received	2015-01-26 19:29
Peer-Review Started	2015-01-27 08:53
To Make the First Decision	2015-03-10 17:55
Return for Revision	2015-03-12 10:34
Revised	2015-03-16 11:01
Second Decision	2015-04-23 08:10
Accepted by Journal Editor-in-Chief	2015-04-24 14:08
Accepted by Company Editor-in-Chief	2015-05-04 17:22
Articles in Press	2015-05-04 17:22
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-07-06 09:37
Publish the Manuscript Online	2015-07-22 13:58

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Shoji Kubo, Shigekazu Takemura, Shogo Tanaka, Hiroji Shinkawa, Takayoshi Nishioka, Akinori Nozawa, Masahiko Kinoshita, Genya Hamano, Tokuji Ito and Yorihisa Urata
Funding Agency and Grant Number
Corresponding Author	Shoji Kubo, MD, Department of Hepato-Biliary-Pancreatic Surgery, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka 545-8585, Japan. m7696493@msic.med.osaka-cu.ac.jp
Key Words	Chronic hepatitis B; Liver resection; Hepatocellular carcinoma; Antiviral therapy; Nucleos(t)ide analogs
Core Tip	Although liver resection is considered the most effective treatment for hepatocellular carcinoma (HCC), treatment outcomes are unsatisfactory because of the high rate of HCC recurrence. Many investigators have demonstrated the effects of viral status on HCC recurrence and post-treatment outcomes. Therapy with interferon and nucleos(t)ide analogs may be useful for preventing HCC recurrence and improving overall survival in patients who have undergone curative resection for hepatitis B virus (HBV)-related HCC. In addition, reactivation of viral replication can occur after liver resection for HBV-related HCC. Antiviral therapy can be recommended for patients to prevent HBV reactivation.
Publish Date	2015-07-22 13:58
Citation	Kubo S, Takemura S, Tanaka S, Shinkawa H, Nishioka T, Nozawa A, Kinoshita M, Hamano G, Ito T, Urata Y. Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2015; 21(27): 8249-8255
URL	http://www.wjgnet.com/1007-9327/full/v21/i27/8249.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i27.8249

Full Article (PDF)	WJG-21-8249.pdf
Full Article (Word)	WJG-21-8249.doc
Manuscript File	16652-Review.doc
Answering Reviewers	16652-Answering reviewers.pdf
Audio Core Tip	16652-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	16652-Conflict-of-interest statement.pdf
Copyright License Agreement	16652-Copyright assignment.pdf
Peer-review Report	16652-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	16652-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	16652-Scientific misconduct check.pdf
Scientific Editor Work List	16652-Scientific editor work list.pdf